OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

McCaskill, Portman Announce PSI Review of EpiPen Drug Pricing

Statement

Date: Sept. 9, 2016
Location: Washington, DC
Issues: Business and Consumers Health and Health Care

In their role as Ranking Member and Chairman of the U.S. Senate Permanent Subcommittee on Investigations, Senator Claire McCaskill (D-MO) and Senator Rob Portman (R-OH) made the following announcement today:

"The Permanent Subcommittee on Investigations has opened a preliminary inquiry concerning Mylan Pharmaceuticals' pricing and competition practices with respect to the EpiPen. Our review of this matter will be robust, thorough, and bipartisan. Parents and school districts in Ohio, Missouri and across the country need affordable access to this life-saving drug, and we share their concern over Mylan's sustained price increases."


Source
arrow_upward